Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
Saved in:
| Title: | Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge. |
|---|---|
| Authors: | Sebban C (AUTHOR), Dussart S (AUTHOR), Fuhrmann C (AUTHOR), Ghesquieres H (AUTHOR), Rodrigues I (AUTHOR), Geoffrois L (AUTHOR), Devaux Y (AUTHOR), Lancry L (AUTHOR), Chvetzoff G (AUTHOR), Bachelot T (AUTHOR), Chelghoum M (AUTHOR), Biron P (AUTHOR), Sebban, Catherine1 (AUTHOR), Dussart, Sophie (AUTHOR), Fuhrmann, Christine (AUTHOR), Ghesquieres, Hervé (AUTHOR), Rodrigues, Isabelle (AUTHOR), Geoffrois, Lionel (AUTHOR), Devaux, Yves (AUTHOR), Lancry, Laurence (AUTHOR) |
| Source: | Supportive Care in Cancer. Sep2008, Vol. 16 Issue 9, p1017-1023. 7p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09414355 |
|---|---|
| DOI: | 10.1007/s00520-007-0383-z |
